Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05349643
Title A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AmMax Bio, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | AUS

Facility Status City State Zip Country Details
AmMax Bio, Clinical Site Sacramento California 95817 United States Details
AmMax Bio, Clinical Site Miami Florida 33136 United States Details
AmMax Bio, Clinical Site Houston Texas 77030 United States Details
AmMax Bio, Clinical Site Camperdown Australia Details
AmMax Bio, Clinical Site Woolloongabba Australia Details
AmMax Bio, Clinical Site Leiden Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field